MA1-216
antibody from Invitrogen Antibodies
Targeting: THRB
ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2
Antibody data
- Antibody Data
- Antigen structure
- References [33]
- Comments [0]
- Validations
- Other assay [10]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-216 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- THRB Monoclonal Antibody (J52)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Description
- MA1-216 detects thyroid hormone receptor (TR) beta-1 in human, mouse, rat, and transformed bacterial cells. This antibody is specific for the TR beta-1 isoform. MA1-216 has been successfully used in Western blot, immunocytochemistry, immunoprecipitation and gel shift procedures. By Western blot, this antibody detects a 52 and a 55 kDa protein representing recombinant TR expressed in E. coli. The two different sizes represent two different translational starting points. Immunocytochemical staining of TR beta-1 in intact GH3 cells with MA1-216 results in nuclear staining. When levels of expression of the transfected receptor are high, cytoplasmic staining is seen along with nuclear staining. Immunoprecipitation and gel super shift experiments show that MA1-216 reacts with the unliganded, liganded, and DNA binding forms of the receptor. The MA1-216 immunogen is purified human TR beta-1 overexpressed in E. coli. This antibody recognizes an epitope in the A/B domain of human TR beta-1, amino acid residues 1-101.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- J52
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Low striatal T3 is implicated in inattention and memory impairment in an ADHD mouse model overexpressing thyroid hormone-responsive protein.
Changes in Thyroid Hormone Signaling Mediate Cardiac Dysfunction in the Tg197 Mouse Model of Arthritis: Potential Therapeutic Implications.
Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells.
Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Thyroid hormone receptor sumoylation is required for preadipocyte differentiation and proliferation.
Genome-wide binding patterns of thyroid hormone receptor beta.
Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats.
Thyroid hormone signalling is altered in response to physical training in patients with end-stage heart failure and mechanical assist devices: potential physiological consequences?
Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.
Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.
Cell-type-dependent thyroid hormone effects on glioma tumor cell lines.
Similarities and differences between two modes of antagonism of the thyroid hormone receptor.
Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta).
Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.
Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy.
Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.
TNF-alpha administration in neonatal cardiomyocytes is associated with differential expression of thyroid hormone receptors: a response prevented by T3.
Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes.
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling.
Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion.
Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
p62, A TFIIH subunit, directly interacts with thyroid hormone receptor and enhances T3-mediated transcription.
Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity.
Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow.
Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow.
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.
Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure.
Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function.
Peroxisome proliferator activated receptor-alpha expression in human liver.
Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
Custodio RJP, Kim M, Sayson LV, Lee HJ, Ortiz DM, Kim BN, Kim HJ, Cheong JH
Communications biology 2021 Sep 20;4(1):1101
Communications biology 2021 Sep 20;4(1):1101
Changes in Thyroid Hormone Signaling Mediate Cardiac Dysfunction in the Tg197 Mouse Model of Arthritis: Potential Therapeutic Implications.
Ntari L, Mantzouratou P, Katsaouni A, Pantos C, Kollias G, Mourouzis I
Journal of clinical medicine 2021 Nov 25;10(23)
Journal of clinical medicine 2021 Nov 25;10(23)
Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells.
Peng X, Zhang Y, Sun Y, Wang L, Song W, Li Q, Zhao R
Oncology letters 2018 Jul;16(1):785-792
Oncology letters 2018 Jul;16(1):785-792
Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE, Tai PW, Barnum MS, Gillis NE, Evans KG, Taber TH, White JH, Tomczak JA, Jaworski DM, Zaidi SK, Lian JB, Stein JL, Stein GS
Endocrinology 2016 Aug;157(8):3278-92
Endocrinology 2016 Aug;157(8):3278-92
Thyroid hormone receptor sumoylation is required for preadipocyte differentiation and proliferation.
Liu YY, Ayers S, Milanesi A, Teng X, Rabi S, Akiba Y, Brent GA
The Journal of biological chemistry 2015 Mar 20;290(12):7402-15
The Journal of biological chemistry 2015 Mar 20;290(12):7402-15
Genome-wide binding patterns of thyroid hormone receptor beta.
Ayers S, Switnicki MP, Angajala A, Lammel J, Arumanayagam AS, Webb P
PloS one 2014;9(2):e81186
PloS one 2014;9(2):e81186
Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats.
Lourbopoulos A, Mourouzis I, Karapanayiotides T, Nousiopoulou E, Chatzigeorgiou S, Mavridis T, Kokkinakis I, Touloumi O, Irinopoulou T, Chouliaras K, Pantos C, Karacostas D, Grigoriadis N
Journal of molecular neuroscience : MN 2014 Sep;54(1):78-91
Journal of molecular neuroscience : MN 2014 Sep;54(1):78-91
Thyroid hormone signalling is altered in response to physical training in patients with end-stage heart failure and mechanical assist devices: potential physiological consequences?
Adamopoulos S, Gouziouta A, Mantzouratou P, Laoutaris ID, Dritsas A, Cokkinos DV, Mourouzis I, Sfyrakis P, Iervasi G, Pantos C
Interactive cardiovascular and thoracic surgery 2013 Oct;17(4):664-8
Interactive cardiovascular and thoracic surgery 2013 Oct;17(4):664-8
Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.
Sharma P, Thakran S, Deng X, Elam MB, Park EA
The Journal of biological chemistry 2013 Jun 7;288(23):16321-16333
The Journal of biological chemistry 2013 Jun 7;288(23):16321-16333
Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.
Mourouzis I, Kostakou E, Galanopoulos G, Mantzouratou P, Pantos C
Molecular and cellular biochemistry 2013 Jul;379(1-2):97-105
Molecular and cellular biochemistry 2013 Jul;379(1-2):97-105
Cell-type-dependent thyroid hormone effects on glioma tumor cell lines.
Liappas A, Mourouzis I, Zisakis A, Economou K, Lea RW, Pantos C
Journal of thyroid research 2011;2011:856050
Journal of thyroid research 2011;2011:856050
Similarities and differences between two modes of antagonism of the thyroid hormone receptor.
Sadana P, Hwang JY, Attia RR, Arnold LA, Neale G, Guy RK
ACS chemical biology 2011 Oct 21;6(10):1096-106
ACS chemical biology 2011 Oct 21;6(10):1096-106
Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta).
Attia RR, Sharma P, Janssen RC, Friedman JE, Deng X, Lee JS, Elam MB, Cook GA, Park EA
The Journal of biological chemistry 2011 Jul 8;286(27):23799-807
The Journal of biological chemistry 2011 Jul 8;286(27):23799-807
Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.
Pantos C, Mourouzis I, Galanopoulos G, Gavra M, Perimenis P, Spanou D, Cokkinos DV
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2010 Sep;42(10):718-24
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2010 Sep;42(10):718-24
Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy.
Wang YY, Morimoto S, Du CK, Lu QW, Zhan DY, Tsutsumi T, Ide T, Miwa Y, Takahashi-Yanaga F, Sasaguri T
Cardiovascular research 2010 Sep 1;87(4):636-46
Cardiovascular research 2010 Sep 1;87(4):636-46
Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.
Kalofoutis C, Mourouzis I, Galanopoulos G, Dimopoulos A, Perimenis P, Spanou D, Cokkinos DV, Singh J, Pantos C
Molecular and cellular biochemistry 2010 Dec;345(1-2):161-9
Molecular and cellular biochemistry 2010 Dec;345(1-2):161-9
TNF-alpha administration in neonatal cardiomyocytes is associated with differential expression of thyroid hormone receptors: a response prevented by T3.
Pantos C, Xinaris C, Mourouzis I, Kokkinos AD, Cokkinos DV
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2008 Oct;40(10):731-4
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2008 Oct;40(10):731-4
Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes.
László V, Dezso K, Baghy K, Papp V, Kovalszky I, Sáfrány G, Thorgeirsson SS, Nagy P, Paku S
Histochemistry and cell biology 2008 Nov;130(5):1005-14
Histochemistry and cell biology 2008 Nov;130(5):1005-14
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos AD, Panagiotou M, Cokkinos DV
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2007 Aug;32(2):333-9
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2007 Aug;32(2):333-9
Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling.
Pantos C, Mourouzis I, Xinaris C, Kokkinos AD, Markakis K, Dimopoulos A, Panagiotou M, Saranteas T, Kostopanagiotou G, Cokkinos DV
European journal of endocrinology 2007 Apr;156(4):415-24
European journal of endocrinology 2007 Apr;156(4):415-24
Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion.
Pantos C, Mourouzis I, Saranteas T, Paizis I, Xinaris C, Malliopoulou V, Cokkinos DV
Basic research in cardiology 2005 Sep;100(5):422-32
Basic research in cardiology 2005 Sep;100(5):422-32
Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
Cao X, Kambe F, Moeller LC, Refetoff S, Seo H
Molecular endocrinology (Baltimore, Md.) 2005 Jan;19(1):102-12
Molecular endocrinology (Baltimore, Md.) 2005 Jan;19(1):102-12
p62, A TFIIH subunit, directly interacts with thyroid hormone receptor and enhances T3-mediated transcription.
Liu Y, Ando S, Xia X, Yao R, Kim M, Fondell J, Yen PM
Molecular endocrinology (Baltimore, Md.) 2005 Apr;19(4):879-84
Molecular endocrinology (Baltimore, Md.) 2005 Apr;19(4):879-84
Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity.
Maruvada P, Dmitrieva NI, East-Palmer J, Yen PM
Molecular biology of the cell 2004 Apr;15(4):1895-903
Molecular biology of the cell 2004 Apr;15(4):1895-903
Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow.
Siebler T, Robson H, Bromley M, Stevens DA, Shalet SM, Williams GR
Bone 2002 Jan;30(1):259-66
Bone 2002 Jan;30(1):259-66
Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow.
Siebler T, Robson H, Bromley M, Stevens DA, Shalet SM, Williams GR
Bone 2002 Jan;30(1):259-66
Bone 2002 Jan;30(1):259-66
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.
Rogatsky I, Zarember KA, Yamamoto KR
The EMBO journal 2001 Nov 1;20(21):6071-83
The EMBO journal 2001 Nov 1;20(21):6071-83
Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure.
d'Amati G, di Gioia CR, Mentuccia D, Pistilli D, Proietti-Pannunzi L, Miraldi F, Gallo P, Celi FS
The Journal of clinical endocrinology and metabolism 2001 May;86(5):2080-4
The Journal of clinical endocrinology and metabolism 2001 May;86(5):2080-4
Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Chen ST, Shieh HY, Lin JD, Chang KS, Lin KH
The Journal of endocrinology 2000 May;165(2):379-89
The Journal of endocrinology 2000 May;165(2):379-89
Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Chen ST, Shieh HY, Lin JD, Chang KS, Lin KH
The Journal of endocrinology 2000 May;165(2):379-89
The Journal of endocrinology 2000 May;165(2):379-89
Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function.
Knipper M, Bandtlow C, Gestwa L, Köpschall I, Rohbock K, Wiechers B, Zenner HP, Zimmermann U
Development (Cambridge, England) 1998 Sep;125(18):3709-18
Development (Cambridge, England) 1998 Sep;125(18):3709-18
Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF
Molecular pharmacology 1998 Jan;53(1):14-22
Molecular pharmacology 1998 Jan;53(1):14-22
Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB
Molecular endocrinology (Baltimore, Md.) 1992 Feb;6(2):248-58
Molecular endocrinology (Baltimore, Md.) 1992 Feb;6(2):248-58
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4 Characterization of TRbeta binding near induced genes. A. Patterns of TRbeta binding depicted at representations of individual target gene loci (LDLR, BCL3, NCOR2,ADSSL1 and SOX7). Blue bars represent genomic binding regions, and the vertical red lines represent peaks, as classified by QuEST. The horizontal black bars are regions analyzed by ChIP-PCR (locations of primer amplification). Observed binding patterns included 5', 3' and intronic binding events, as shown in genomic data tracks (UCSC Genome Browser). Putative regulatory elements, identified through sequence analysis of the genomic regions indicated, are depicted below bound regions in which they occur. B. QPCR of ChIP analysis confirming DNA binding in regulatory regions of genes. C. Realtime PCR analysis depicting enhancement of transcription of individual loci in Fig. 4A by T3 in the presence of TRbeta. (*P
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 6 Links between TR Binding and Adm Transcription. A. Graph showing results of realtime PCR analysis of adm transcription in the B7B cells after six hours of T3 treatment +/-10 ug/ml CHX cotreatment of B7B cells. B. Patterns of TRbeta binding peaks at the adm locus (UCSC Genome Browser), in similar format to Fig. 4 . TRbeta binding events clustered into four regions (R1, R2, R3, R4), upstream and downstream of this transcript, as well as a substantial amount of binding immediately proximal to the transcriptional start site. C. Binding of TRbeta was confirmed by realtime ChIP PCR analysis in B7B cells at the regions indicated (ChIP primers are depicted by horizontal bars in B). D. The proximal promoter region of adm (corresponding to R2) conferred T3-dependent increases in luciferase activity upon a standard reporter after transfection into B7B. E. Results of gel shift confirming direct TRbeta binding to two putative response elements, designated TRE-1 and TRE-2 that were found in R2 at positions marked in Fig. 6B . Individual lanes show shifts obtained with elements and RXRalpha-TRbeta +/- competitor DNA or mutated versions of both elements. F. Luciferase reporter assays confirming that TRE-1 and TRE-2 confer T3 responsiveness on a reporter gene. (*P
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 7 Intergenic binding events. A. Three intergenic binding peaks were selected and analyzed for the presence of recognizable TR binding motifs (sequences of motifs listed). B. Results of qPCR ChIP analysis confirming binding of TRbeta to the intergenic regions depicted in Fig. 7A (top panels) and induction of H3 acetylation near sites (bottom panels). C. Results of luciferase reporter assays, with indicated constructs containing intergenic elements described in Fig. 7A , confirming that each element confers T3 induction. (*P
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 10 Effects of TH replacement on TH-related proteins in THRSP OE mice. The TH-related proteins were evaluated following 7 days of LT3 and LT4 (10 mg kg -1 ) treatment. On the last day of the treatment, the brains were harvested, and the striatum was subjected to western blot analysis. a Representative blots for specific protein targets. b MCT8, c TRalpha, and d TRbeta protein levels ( n = 6 mice/group; b two-way ANOVA, F (1,30) = 4.96, P = 0.034; c two-way ANOVA, F (1,30) = 14.4, P < 0.001; d two-way ANOVA, F (1,30) = 0.123, P = 0.728). TH replacement improved the striatal MCT8 and TRalpha levels in THRSP OE mice. Values are presented as the mean +- S.E.M. * P < 0.05 (relative to WT) and # P < 0.05. ## P < 0.01 (relative to VEH treatment), by two-way ANOVA with Bonferroni's multiple comparison tests.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 2 Reduction of TRbeta1 in Tg197 LV samples and female-specific reduction of Akt activation. Densitometric assessment in arbitrary units and representative Western blots of thyroid hormone receptor alpha1 nuclear expression (TRalpha1, A ), thyroid hormone receptor beta1 nuclear expression (TRbeta1, B ) and phosphorylated and total p38 MAPK ( C ) in left ventricle of WTC57BL/6JxCBA (WT, n = 4 per gender) and Tg197 ( n = 6 per gender) male and female mice. Values are represented in mean +- SEM; * p < 0.05 (H3: Histone 3).